Acetazolamide-challenged perfusion magnetic resonance imaging for assessment of cerebrovascular reserve capacity in patients with symptomatic middle cerebral artery stenosis: Comparison with technetium-99m-hexamethylpropyleneamine oxime single-photon emission computed tomography

Clinical Imaging

Volumn 35, Issue 6, 2011, Pages 413-420

  Kim, Hyun Jeong ^a   Kim, Tae Woo ^a   Ryu, Seon Young ^a   Yang, Po Song ^a   Kwon, Min Jeong ^a   Kim, Ji Chang ^a   Lee, Yeon Soo ^a   Lee, Hyung Jin ^a   Yang, Ji Ho ^a   Kim, Jae Kyun ^b   Chung, Yong An ^c   Oh, Eun Young ^a   Lee, Sang Bong ^a  

^a Daejeon St Mary's Hospital   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Brain ischemia; Intracranial arteriosclerosis; Magnetic resonance imaging; Perfusion imaging; Tomography, emission computed, single photon

Indexed keywords

BRAIN ISCHEMIA; CEREBRAL BLOOD FLOW; CEREBRAL BLOOD VOLUME; INTERNAL CAROTID ARTERY; INTRACRANIAL ARTERIOSCLEROSIS; MIDDLE CEREBRAL ARTERY; PERFUSION IMAGING; PERFUSION MRI; REGION OF INTEREST; RESERVE CAPACITY;

BLOOD; BLOOD VESSELS; BRAIN; HEMODYNAMICS; MAGNETIC LOGIC DEVICES; MAGNETIC RESONANCE IMAGING; PARTICLE BEAMS; PHOTONS; RATING; RESONANCE; TECHNETIUM; TOMOGRAPHY;

SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

ACETAZOLAMIDE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN INFARCTION; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR RESERVE CAPACITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; INTERNAL CAROTID ARTERY OCCLUSION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVOUS SYSTEM PARAMETERS; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REGION OF INTEREST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

ACETAZOLAMIDE; ADULT; AGED; AGED, 80 AND OVER; CARBONIC ANHYDRASE INHIBITORS; CEREBROVASCULAR CIRCULATION; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 80055040041     PISSN: 08997071     EISSN: 18734499     Source Type: Journal    
DOI: 10.1016/j.clinimag.2011.03.001     Document Type: Article

References (21)

1. Derdeyn CP, Grubb RL, Powers WJ Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology 1999, 53:251-259.
2. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it?. Stroke 2001, 32:2110-2116.
3. Yamamoto S, Watanabe M, Uematsu T, Takasawa K, Nukata M, Kinoshita N Correlation of angiographic circulation time and cerebrovascular reserve by acetazolamide-challenged single photon emission CT. AJNR Am J Neuroradiol 2004, 25:242-247.
4. Ma J, Mehrkens JH, Holtmannspoetter M, Linke R, Schmid-Elsaesser R, Steiger HJ, Brueckmann H, Bruening R Perfusion MRI before and after acetazolamide administration for assessment of cerebrovascular reserve capacity in patients with symptomatic internal carotid artery (ICA) occlusion: comparison with 99mTc-ECD SPECT. Neuroradiology. 2007, 49:317-326.
5. Nighoghossian N, Berthezene Y, Meyer R, Cinotti L, Adeleine P, Philippon B, Froment JC, Trouillas P Assessment of cerebrovascular reactivity by dynamic susceptibility contrast-enhanced MR imaging. J Neurol Sci 1997, 149:171-176.
6. Sacco RL, Kargman DE, Gu Q, Zamanillo MC Race-ethnicity and determinates of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Study. Stroke 1995, 26:14-20.
7. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996, 27:1974-1980.
8. Rincon F, Sacco RL, Kranwinkel G, Xu Q, Paik MC, Boden-Albala B, Elkind MS Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Study. Cerebraovascular Dis 2009, 28:65-71.
9. Kim JS, Caplan LR, Lawrence Wong KS Epidemiology; intracranial atherosclerosis 2008, 33-44. Wiley-Blackwell, Oxford.
10. Suh DC, Kim JK, Choi JW, Choi BS, Pyun HW, Choi YJ, Kim MH, Yang HR, Ha HI, Kim SJ, Lee DH, Choi CG, Hahm KD, Kim JS Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol 2008, 29:781-785.
11. Lee TH, Kim DH, Lee BH, Kim HJ, Choi CH, Park KP, Jung DS, Kim S, Moon TY Preliminary results of endovascular stent-assisted angioplasty for symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol 2005, 26:166-174.
12. Derdeyn CP, Powers WJ, Grubb RL Hemodynamic effects of middle cerebral artery stenosis and occlusion. AJNR Am J Neuroradiol 1998, 19:1463-1469.
13. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274:1017-1025.
14. Cardiogenic brain embolism Cerebral embolism task force. Arch Neurol 1986, 43:71-84.
15. Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Nagren K, Darcourt J, Tatsch K, Van Laere KJ EANM procedure guideline for brain perfusion SPECT using (99m)Tc-labelled radiopharmaceuticals, version 2. Eur J Nucl Med Mol Imaging 2009, 36:2093-2102.
16. Matsuda H, Higashi S, Kinuya K, Tsuji S, Nozaki J, Sumiya H, Hisada K, Yamashita J SPECT evaluation of brain perfusion reserve by the acetazolamide test using Tc-99m HMPAO. Clin Nucl Med 1991, 16:572-579.
17. Chen A, Shyr MH, Chen TY, Lai HY, Lin CC, Yen PS Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease. AJNR Am J Neuroradiol 2006, 27:1876-1881.
18. Rim NJ, Kim HS, Shin YS, Kim SY Which CT perfusion parameter best reflects cerebrovascular reserve? Correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in moyamoya patients. AJNR Am J Neuroradiol 2008, 29:1658-1663.
19. Kim JH, Lee SJ, Shin T, Kang KH, Choi PY, Gong JC, Choi NC, Lim BH Correlative assessment of hemodynamic parameters obtained with T2*-weighted perfusion MR imaging and SPECT in symptomatic carotid artery occlusion. AJNR Am J Neuroradiol 2000, 21:1450-1456.
20. Kim E, Sohn CH, Na DG, Kim JE, Chang KH, Kim JH, Jeon SJ Perfusion computed tomography evaluation of cerebral hemodynamic impairment in patients with unilateral chronic steno-occlusive disease: a comparison with the acetazolamide challenge 99mTc-hexamethylpropyleneamine oxime single-photon emission computed tomography. J Comput Assist Tomogr 2009, 33:546-551.
21. JW Choi, JK Kim, BS Choi, HK Lim, SJ Kim, JS Kim, DC Suh, Angiographic pattern of symptomatic severe m1 stenosis: comparison with presenting symptoms, infarct patterns, perfusion status, and outcome after recanalization. Cerebrovasc Dis 29:297-303.